CINCINNATI--(BUSINESS WIRE)--CinFina Pharma, a CinRx portfolio company dedicated to advancing a portfolio of high-impact treatment options for obesity, will present two posters at ObesityWeek ...

AstraZeneca and TotalEnergies are among the stocks that fell into undervalued territory. We sell different types of products and services to both investment professionals and individual investors ...

For the first time, this early data demonstrates the utility of the MyPhenome test in predicting future weight gain, a key area of obesity care. The study showed participants with abnormal satiation ...

Here are the details about Yvette Nicole Brown’s weight loss and how she destigmatized obesity. Overall health is important for her, not a number on the scale!

CINCINNATI--(BUSINESS WIRE)--CinFina Pharma, a CinRx portfolio company dedicated to advancing a portfolio of high-impact treatment options for obesity, today announced topline interim data from ...

Palatin (PTN) Technologies announced that preclinical data from the Company’s melanocortin 4 receptor, or MC4R, selective PL7737 obesity program will be highlighted in a poster presentation at ...

Congruence has been awarded the Neuroscience Section Blitz Talk Award for transformative research in MC4R-related early-onset genetic obesity - -Congruence's insights into the biology and ...

Title: "Discovery of Small Molecule Correctors for Treatment of Early-onset MC4R-deficient Genetic Obesity"Poster Number: 065Session Date and Time: 11/3/2024, 7.30pm – 8.30pmPresenting Author ...

Congruence has been awarded the Neuroscience Section Blitz Talk Award for transformative research in MC4R-related early-onset genetic obesity - -Congruence's insights into the biology and pharmacology ...